{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:41:13Z","timestamp":1793133673413,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.ygyno.2007.11.020","type":"journal-article","created":{"date-parts":[[2008,1,31]],"date-time":"2008-01-31T16:07:59Z","timestamp":1201795679000},"page":"619-626","source":"Crossref","is-referenced-by-count":426,"title":["Folate receptor alpha as a tumor target in epithelial ovarian cancer"],"prefix":"10.1016","volume":"108","author":[{"given":"Kimberly R.","family":"Kalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann L.","family":"Oberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary L.","family":"Keeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa J.H.","family":"Christianson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S.","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith L.","family":"Knutson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn C.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2007.11.020_bib1","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2741\/1815","article-title":"Role of folate receptor genes in reproduction and related cancers","volume":"11","author":"Elnakat","year":"2006","journal-title":"Front Biosci"},{"key":"10.1016\/j.ygyno.2007.11.020_bib2","doi-asserted-by":"crossref","first-page":"C517","DOI":"10.1152\/ajpcell.00006.2004","article-title":"Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy","volume":"287","author":"Sandoval","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.ygyno.2007.11.020_bib3","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.addr.2004.01.002","article-title":"A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro","volume":"56","author":"Kamen","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ygyno.2007.11.020_bib4","first-page":"3396","article-title":"Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues","volume":"52","author":"Weitman","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2007.11.020_bib5","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1073\/pnas.88.13.5572","article-title":"Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis","volume":"88","author":"Leamon","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ygyno.2007.11.020_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10555-007-9048-0","article-title":"The folate receptor: what does it promise in tissue-targeted therapeutics?","volume":"26","author":"Salazar","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.ygyno.2007.11.020_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/1389201053642376","article-title":"Targeting therapeutic and imaging agents to folate receptor positive tumors","volume":"6","author":"Reddy","year":"2005","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.ygyno.2007.11.020_bib8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ab.2004.12.026","article-title":"Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay","volume":"338","author":"Parker","year":"2005","journal-title":"Anal Biochem"},{"key":"10.1016\/j.ygyno.2007.11.020_bib9","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1200\/JCO.2006.05.9311","article-title":"T cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer","volume":"24","author":"Knutson","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2007.11.020_bib10","first-page":"6","article-title":"Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha","volume":"7","author":"Ebel","year":"2007","journal-title":"Cancer Immun"},{"key":"10.1016\/j.ygyno.2007.11.020_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/(SICI)1097-0215(19980417)79:2<121::AID-IJC4>3.0.CO;2-V","article-title":"Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer","volume":"79","author":"Toffoli","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2007.11.020_bib12","series-title":"Principles and practice of gynecologic oncology","first-page":"895","article-title":"Epithelial ovarian cancer","author":"Ozols","year":"2005"},{"key":"10.1016\/j.ygyno.2007.11.020_bib13","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1172\/JCI27698","article-title":"Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity","volume":"116","author":"Chien","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ygyno.2007.11.020_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ijc.2910570719","article-title":"New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma","volume":"8","author":"Franklin","year":"1994","journal-title":"Int J Cancer Suppl"},{"key":"10.1016\/j.ygyno.2007.11.020_bib15","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1158\/1055-9965.EPI-05-0260","article-title":"Multivitamin and alcohol intake and folate receptor alpha expression in ovarian cancer","volume":"14","author":"Kelemen","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2007.11.020_bib16","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2007.11.020_bib17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.4065\/82.6.751","article-title":"Current management strategies for ovarian cancer","volume":"82","author":"Aletti","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ygyno.2007.11.020_bib18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11912-005-0010-4","article-title":"Secondary cytoreduction for patients with recurrent ovarian cancer","volume":"7","author":"Diaz-Montes","year":"2005","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.ygyno.2007.11.020_bib19","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.21845","article-title":"Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma","volume":"106","author":"Chi","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2007.11.020_bib20","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","article-title":"Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study","volume":"25","author":"Winter","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2007.11.020_bib21","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/ijc.22811","article-title":"Folate receptor overexpression is associated with poor outcome in breast cancer","volume":"121","author":"Hartmann","year":"2007","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2007.11.020_bib22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ygyno.2007.05.018","article-title":"Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas","volume":"107","author":"Allard","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2007.11.020_bib23","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1158\/1078-0432.CCR-06-1343","article-title":"The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate","volume":"13","author":"Yang","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2007.11.020_bib24","first-page":"5791","article-title":"Gene transfection and expression of the ovarian carcinoma marker folate binding protein on NIH\/3T3 cells increases cell growth in vitro and in vivo","volume":"53","author":"Bottero","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2007.11.020_bib25","first-page":"5791","article-title":"Gene transfection and expression of the ovarian carcinoma marker folate binding protein on NIH\/3T3 cells increases cell growth in vitro and in vivo","volume":"53","author":"Bottero","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2007.11.020_bib26","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1158\/1535-7163.1505.3.12","article-title":"Antisense oligonucleotides targeted to the human alpha folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment","volume":"3","author":"Jhaveri","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ygyno.2007.11.020_bib27","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/sj.gt.3301962","article-title":"Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies","volume":"10","author":"Figini","year":"2003","journal-title":"Gene Ther"},{"key":"10.1016\/j.ygyno.2007.11.020_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.22853","article-title":"Comparative preclinical activity of the folate-targeted Vinca alkaloid conjugates EC140 and EC145","author":"Leamon","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2007.11.020_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00280-005-0151-z","article-title":"Folate receptor specific anti-tumor activity of folate\u2013mitomycin conjugates","volume":"58","author":"Reddy","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ygyno.2007.11.020_bib30","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jps.20457","article-title":"Folate receptor-mediated drug targeting: from therapeutics to diagnostics","volume":"94","author":"Hilgenbrink","year":"2005","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ygyno.2007.11.020_bib31","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00259-006-0111-9","article-title":"Preclinical evaluation of novel organometallic 99mTc-folate and 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting","volume":"33","author":"Muller","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ygyno.2007.11.020_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/cbr.2006.21.49","article-title":"Preparation and in vitro and in vivo evaluation of technetium-99m-labeled folate and methotrexate conjugates as tumor imaging agents","volume":"21","author":"Okarvi","year":"2006","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.ygyno.2007.11.020_bib33","first-page":"700","article-title":"Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results","volume":"44","author":"Siegel","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ygyno.2007.11.020_bib34","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.addr.2004.01.006","article-title":"Folate-mediated targeting of T cells to tumors","volume":"56","author":"Roy","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ygyno.2007.11.020_bib35","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1073\/pnas.92.20.9057","article-title":"Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis","volume":"92","author":"Kranz","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ygyno.2007.11.020_bib36","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1021\/bc050335b","article-title":"Synthesis and grafting of thioctic acid\u2013PEG\u2013folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells","volume":"17","author":"Dixit","year":"2006","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.ygyno.2007.11.020_bib37","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1158\/1078-0432.CCR-06-0992","article-title":"The use of a tropism-modified measles virus in folate receptor-targeted virotherapy of ovarian cancer","volume":"12","author":"Hasegawa","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2007.11.020_bib38","first-page":"5329","article-title":"Folate-binding protein is a marker for ovarian cancer","volume":"51","author":"Campbell","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2007.11.020_bib39","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S","article-title":"Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications","volume":"73","author":"Ross","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2007.11.020_bib40","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1699-0463.1995.tb01420.x","article-title":"Folate receptor in malignant effusions of ovarian carcinoma","volume":"103","author":"Holm","year":"1995","journal-title":"Apmis"},{"key":"10.1016\/j.ygyno.2007.11.020_bib41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/abbi.1999.1188","article-title":"High-affinity folate receptor in human ovary, serous ovarian adenocarcinoma, and ascites: radioligand binding mechanism, molecular size, ionic properties, hydrophobic domain, and immunoreactivity","volume":"366","author":"Holm","year":"1999","journal-title":"Arch Biochem Biophys"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825807009328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825807009328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T05:45:49Z","timestamp":1684215949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825807009328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0090825807009328"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2007.11.020","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}